C-B5-02: H1N1 Vaccine Safety Monitoring in the Vaccine Safety Datalink Project: New Challenges and Useful Lessons

Clinical Medicine and Research - United States
doi 10.3121/cmr.2010.943.c-b5-02
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Marshfield Clinic Research Foundation

Related search

Safety of Trivalent Inactivated Influenza Vaccine in Children Aged 24 to 59 Months in the Vaccine Safety Datalink

Archives of Pediatrics & Adolescent Medicine
2011English

Vaccine Update: Recent Progress With Novel Vaccines, and New Approaches to Safety Monitoring and Vaccine Shortage

Journal of Clinical Pharmacology
Pharmacology
2018English

Vaccine Safety: Myths and Misinformation

Frontiers in Microbiology
Microbiology
2020English

Vaccine Safety and Social Media in China

American Journal of Infection Control
EpidemiologyPublic HealthHealth PolicyInfectious DiseasesEnvironmentalOccupational Health
2016English

Canadian Vaccine Research Networks: Vaccine Safety Resources for Canada

Canada Communicable Disease Report
2015English

Immunogenicity, Safety and Consistency of New Trivalent Inactivated Influenza Vaccine

Vaccine
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
2008English

The Global Vaccine Safety Initiative: Enhancing Vaccine Pharmacovigilance Capacity at Country Level

Bulletin of the World Health Organization
EnvironmentalPublic HealthOccupational Health
2014English

Postlicensure Safety Surveillance for Varicella Vaccine

JAMA - Journal of the American Medical Association
Medicine
2000English

Measles-Mumps-Rubella and Other Measles-Containing Vaccines Do Not Increase the Risk for Inflammatory Bowel DiseaseA Case-Control Study From the Vaccine Safety Datalink Project

Archives of Pediatrics & Adolescent Medicine
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy